DDOG vs PFE: Which Is the Better Buy?

Side-by-side comparison of Datadog, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-09.
Datadog, Inc. · Technology
$261.09
+45.0% upside to fair value
Grade B High Quality
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
DDOG has more upside to fair value (+45.0%). PFE trades at a lower forward P/E (19.2x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric DDOG PFE
Current Price $261.09 $25.22
Fair Value Estimate $378.58 $25.92
Upside to Fair Value +45.0% +2.8%
Market Cap $92.9B $143.7B
Forward P/E 678.5x 19.2x
EV / EBITDA 410.4x 12.3x
Price / Sales 25.3x 2.3x
Price / FCF 86.1x 15.2x
Revenue Growth YoY +32.2% +5.4%
Gross Margin 79.9% 69.3%
Operating Margin -0.7% 23.4%
Return on Equity 3.8% 8.4%
Dividend Yield 0% 0%
FCF Yield 1.16% 6.6%
Analyst Consensus Strong Buy Hold
Investment Thesis
DDOG — Datadog, Inc.
Datadog, Inc. is a leading provider of cloud-scale monitoring and analytics software for developers, IT operations teams, and business users in the technology sector. The company exhibits strong business quality with a durable competitive moat supported by high gross margins of 79.9% and rapid revenue growth of 32.2% in the most recent quarter. Despite this, the stock trades at a very high valuat…
PFE — Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
Metric DDOG PFE
Zone Low $283.94 $19.44
Zone High $321.79 $22.03
In Buy Zone? Yes No
← DDOG Research    PFE Research →    All Research